As of Nov 17
| 0.00 / 0.00%|
The 8 analysts offering 12-month price forecasts for Insmed Inc have a median target of 38.00, with a high estimate of 54.00 and a low estimate of 17.00. The median estimate represents a +25.29% increase from the last price of 30.33.
The current consensus among 8 polled investment analysts is to Buy stock in Insmed Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.